Keyphrases
Novel Immunotherapy
100%
Prostate Cancer
100%
Racial Disparities
100%
African American Men
100%
African American Population
100%
African American
37%
Clinical Trials
25%
Prostate Cancer Risk
25%
United States
12%
Improved Outcomes
12%
Oncogenesis
12%
Comorbidity
12%
Clinical Outcomes
12%
Socioeconomic Factors
12%
Risk Stratification
12%
High Mortality
12%
Therapeutic Intervention
12%
Tumor Microenvironment
12%
High Incidence
12%
Clinical Data
12%
Treatment Options
12%
High-risk Disease
12%
Molecular Differences
12%
Targeted Therapy
12%
Diagnosis Treatment
12%
Disease-based
12%
Immunological Profile
12%
Genomic Data
12%
Caucasian American
12%
Cancer Burden
12%
Genetic Profile
12%
PARP Inhibitor (PARPi)
12%
New Treatment Options
12%
Specific Populations
12%
Precision Medicine
12%
Obesity-related Hypertension
12%
Early Identification
12%
Access to Care
12%
Genomic Profiling
12%
Immune Checkpoint Inhibitors
12%
Access Issues
12%
Clinical Profile
12%
Obesity Diabetes
12%
Clinical Prognosis
12%
Clinical Genomics
12%
Tumor Biology
12%
Genomic Difference
12%
Educational Initiatives
12%
Sipuleucel-T
12%
Equal Outcomes
12%
Concise Description
12%
Lifestyle Issues
12%
Dietary Issues
12%
Medicine and Dentistry
Immunotherapy
100%
Prostate Cancer
100%
Racial Disparity
100%
Clinical Trial
33%
Cancer Incidence
33%
Diabetes
16%
Malignant Neoplasm
16%
Disease
16%
Carcinogenesis
16%
Risk Stratification
16%
Targeted Therapy
16%
Personalized Medicine
16%
PARP Inhibitor
16%
Tumor Microenvironment
16%
Immune Checkpoint Inhibitor
16%
Tumor Biology
16%
Sipuleucel T
16%
Comorbidity
16%